A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females
Phase of Trial: Phase I
Latest Information Update: 08 Feb 2017
At a glance
- Drugs Semaglutide (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 03 Feb 2017 Status changed from active, no longer recruiting to completed.
- 02 Dec 2016 Planned End Date changed from 1 Feb 2017 to 1 Dec 2017.
- 02 Dec 2016 Planned primary completion date changed from 1 Feb 2017 to 1 Dec 2017.